Analysts expect Quipt Home Medical Corp. (NASDAQ:QIPT – Get Rating) to announce sales of $34.45 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Quipt Home Medical’s earnings, with the lowest sales estimate coming in at $34.40 million and the highest estimate coming in at $34.50 million. Quipt Home Medical posted sales of $24.24 million in the same quarter last year, which suggests a positive year over year growth rate of 42.1%. The business is scheduled to issue its next quarterly earnings report on Tuesday, June 7th.
On average, analysts expect that Quipt Home Medical will report full year sales of $143.64 million for the current financial year, with estimates ranging from $129.20 million to $153.50 million. For the next year, analysts forecast that the firm will post sales of $207.27 million, with estimates ranging from $165.30 million to $236.50 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Quipt Home Medical.
Quipt Home Medical (NASDAQ:QIPT – Get Rating) last released its quarterly earnings data on Thursday, January 27th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $29.12 million during the quarter. Quipt Home Medical had a negative net margin of 8.86% and a negative return on equity of 4.36%.
QIPT has been the subject of several research reports. Raymond James reaffirmed an “outperform” rating and issued a $11.50 price target on shares of Quipt Home Medical in a research report on Wednesday, February 16th. Zacks Investment Research raised shares of Quipt Home Medical from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 9th. Stifel Nicolaus upped their price target on shares of Quipt Home Medical from C$12.40 to C$12.75 and gave the stock a “buy” rating in a research report on Wednesday, November 17th. Finally, upped their price target on shares of Quipt Home Medical from C$10.00 to C$11.00 and gave the stock a “buy” rating in a research report on Friday, November 19th. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Quipt Home Medical has an average rating of “Buy” and an average price target of $9.80.
Shares of QIPT traded down $0.12 during mid-day trading on Wednesday, hitting $4.56. The company’s stock had a trading volume of 914 shares, compared to its average volume of 68,375. The company’s 50-day moving average is $5.24 and its 200-day moving average is $5.70. Quipt Home Medical has a 52-week low of $4.03 and a 52-week high of $8.40. The firm has a market capitalization of $152.54 million and a price-to-earnings ratio of -14.63. The company has a current ratio of 1.70, a quick ratio of 1.38 and a debt-to-equity ratio of 0.30.
Several large investors have recently added to or reduced their stakes in QIPT. Public Employees Retirement System of Ohio purchased a new stake in Quipt Home Medical during the second quarter worth $273,000. Geode Capital Management LLC purchased a new stake in Quipt Home Medical during the second quarter worth $86,000. Independent Advisor Alliance purchased a new stake in Quipt Home Medical during the third quarter worth $66,000. First Manhattan Co. lifted its holdings in Quipt Home Medical by 56.0% during the third quarter. First Manhattan Co. now owns 446,250 shares of the company’s stock valued at $2,815,000 after purchasing an additional 160,250 shares in the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new position in Quipt Home Medical during the third quarter valued at $641,000. Hedge funds and other institutional investors own 21.35% of the company’s stock.
Quipt Home Medical Company Profile (Get Rating)
Quipt Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment.
See Also
Get a free copy of the Zacks research report on Quipt Home Medical (QIPT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Want More Great Investing Ideas?
Receive News & Ratings for Quipt Home Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Quipt Home Medical and related companies with MarketBeat.com’s FREE daily email newsletter.